...PF, a preservative-free formulation of Timoptic; Timoptic XE, a gel-forming formulation of Timoptic; and Saflutantafluprost... ...$52.8 million in cash. Earlier this year, Akorn acquired U.S. rights to ophthalmic drug Zioptantafluprost... ...PF, a preservative-free formulation of Timoptic; Timoptic XE, a gel-forming formulation of Timoptic; and Saflutantafluprost...
...Merck received a complete response letter from FDA for an NDA for tafluprost to treat elevated... ...did not disclose details of the letter, said it plans to discuss it with FDA. Tafluprost... ...Osaka, Japan Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Product: Tafluprost ( DE-085 , MK-2452...